| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Medical Officer
1 company
Robert Gut is Director at QURE. From September 2018 to June 2026, the filings on record show 0 open-market purchases and 16 sales. Robert Gut's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $770K at current prices.
Historically, Robert Gut's trades have earned a middling insider score of 62/100 across 12 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +2.2%.
The QURE filings lean toward selling, a net 133,204 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2021 | QURE Uniqure N.V. | Director | Sell | 1,300 | $36.98 | $48,074.00 | -3.0% | |
| Jan 26, 2021 | QURE Uniqure N.V. | Chief Medical Officer | Sell | 604 | $39.09 | $23,610.36 | -1.5% | |
| Sep 21, 2020 | QURE Uniqure N.V. | Chief Medical Officer | Sell | 4,352 | $39.12 | $170,250.24 | -9.5% | |
| Jun 23, 2020 | QURE Uniqure N.V. | Chief Medical Officer | Sale+OE | 26,875 | $70.00 | $1,881,250.00 | -36.9% | |
| Jan 28, 2020 | QURE Uniqure N.V. | Chief Medical Officer | Sell | 7,493 | $60.18 | $450,954.21 | -21.2% | |
| Sep 19, 2019 | QURE Uniqure N.V. | Chief Medical Officer | Sell | 4,769 | $47.16 | $224,906.04 | -11.9% |